December 11, 2017 / 12:16 PM / in 10 months

BRIEF-Prometic's PBI-4050 Receives Promising Innovative Medicine Designation From UK MHRA

Dec 11 (Reuters) - Prometic Life Sciences Inc:

* PROMETIC’S PBI-4050 RECEIVES PROMISING INNOVATIVE MEDICINE (PIM) DESIGNATION FROM THE UK MHRA IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below